Literature DB >> 30964114

The efficacy of endoscopic stenting combined with laparoscopy in the treatment of left colon cancer with obstruction.

Wenming Li1, Xin Jin1, Guogang Liang1.   

Abstract

CONTEXT: Endoscopic self-expandable metal stents (SEMSs) are the bridge of obstructive colorectal cancer surgery. The debate is still open on whether the procedure and effects can be the same between the SEMS combined obstructive colon cancer resection and nonobstructive colon cancer resection, both of which were under laparoscopic. AIMS: This retrospective study was designed to compare whether the same effects could be achieved in both resections. SETTINGS AND
DESIGN: The retrospective analysis was from September 2016 to November 2017. In the observation group (OG), 20 patients hospitalized for obstruction of the left colon cancer were included, who received obstructive colon cancer laparoscopic resection (LR) combined with SEMS insertion. In control group (CG), 20 patients were randomly selected, who underwent nonobstructive colon cancer LR during this period. SUBJECTS AND METHODS: The differences between the two groups were compared, including operation time, intraoperative blood loss, the number of removed lymph nodes, postoperative anal exhaust time, and hospital stay.
RESULTS: Both groups were comparable in the age, gender, weight, the distribution of tumor, lymph node metastasis, tumor, node, and metastasis staging, operation time, intraoperative blood loss, the number of removed lymph nodes, and postoperative anal exhaust time. The hospital stay was 15.2 ± 1.3 days and 14.2 ± 1.5 days in OG and CG, respectively, and it was longer in OG than that of in CG (P = 0.032).
CONCLUSIONS: Obstructive colon cancer LR combined with SEMS insertion was a safe and feasible radical treatment strategy. The same level of procedure and effects could be achieved, compared to that of nonobstructive colon cancer LR.

Entities:  

Keywords:  Effects; left colon cancer obstructive; self-expandable metal stent

Mesh:

Year:  2019        PMID: 30964114     DOI: 10.4103/jcrt.JCRT_111_18

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

1.  Efficacy and Safety of rCCK96-104PE38 Targeted Drug in the General Surgical Treatment of Colon Cancer.

Authors:  Wenbin Cao; Bo Zhang; Yang Liu
Journal:  Biomed Res Int       Date:  2022-06-08       Impact factor: 3.246

2.  Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy.

Authors:  Fang-Ze Wei; Shi-Wen Mei; Jia-Nan Chen; Zhi-Jie Wang; Hai-Yu Shen; Juan Li; Fu-Qiang Zhao; Zheng Liu; Qian Liu
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

Review 3.  Biopsy sampling during self-expandable metallic stent placement in acute malignant colorectal obstruction: a narrative review.

Authors:  Sigrid Skov Bennedsgaard; Lene Hjerrild Iversen
Journal:  World J Surg Oncol       Date:  2021-02-14       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.